-
1 Comment
BlackRock Science and Technology Trust II is currently in a long term uptrend where the price is trading 16.0% above its 200 day moving average.
From a valuation standpoint, the stock is 53.5% cheaper than other stocks from the sector with a price to sales ratio of 2.0.
BlackRock Science and Technology Trust II's total revenue rose by 121.3% to $6M since the same quarter in the previous year.
Its net income has increased by 302.9% to $430M since the same quarter in the previous year.
Finally, its free cash flow grew by 140.1% to $46M since the same quarter in the previous year.
Based on the above factors, BlackRock Science and Technology Trust II gets an overall score of 5/5.
| ISIN | US09260K1016 |
|---|---|
| Sector | Financial Services |
| Industry | Asset Management |
| Exchange | NYSE |
| CurrencyCode | USD |
| Market Cap | 2B |
|---|---|
| PE Ratio | 3.74 |
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | nan |
BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the science and technology sectors. It primarily invests in growth stocks of companies across all market capitalizations. BlackRock Science and Technology Term Trust was formed in June 2019 and is domiciled in the United States.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BSTZ using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
